Amelioration of negative symptoms in schizophrenia by escitalopram: A double-blind, placebo-controlled clinical trial

Clinical Schizophrenia and Related Psychoses

Volumn 1, Issue 3, 2007, Pages 255-258

  Shafti, Saeed Shoja ^a,b  

^a Razi Psychiatric Center   (Iran)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Escitalopram; Negative Symptoms; Schizophrenia

Indexed keywords

ESCITALOPRAM; HALOPERIDOL; PLACEBO; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; PARKINSONISM; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREMOR;

EID: 67649718288     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.1.3.4     Document Type: Article

References (17)

1. Evins AE, Gof DC. Adjunctive antidepressant drug therapies in the treatment of negative symptoms of schizophrenia. CNS Drugs 1996;6:130-147.
2. Gof DC, Evins AE. Negative symptoms in schizophrenia: neurobiological models and treatment response. Harv Rev Psychiatry 1998;6(2):59-77.
3. Siris SG, Mason SE, Bermanzohn PC, Alvir JM, McCorry TA. Adjunctive imipramine maintenance in post-psychotic depression/negative symptoms. Psychopharmacol Bull 1990;26(1):91-94.
4. Silver H, Nassar A. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study. Biol Psychiatry 1992; 31(7):698-704.
5. Spina E, De Domenico P, Ruello C, Longobardo N, Gitto C, Ancione M, et al. Adjunctive fuoxetine in the treatment of negative symptoms in chronic schizophrenic patients. Int Clin Psychopharmacol 1994;9(4):281-285.
6. Gof DC, Midha KK, Sarid-Segal O, Hubbard J W, Amico E. A placebo-controlled trial of fuoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology (Berl) 1995;117(4):417-423.
7. Salokangas RK, Saarijarvi S, Taiminen T, Kallioniemi H, Lehto H, Niemi H, et al. Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study. Acta Psychiatr Scand 1996;94(3):175-180.
8. Carpenter W. Pharmacotherapy of schizophrenia: negative symptoms. Am J Psychiatr 1997;154(Suppl 4):123.
9. Collins AD, Dundas J. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics. Br J Psychiatry 1967;113(505):1425-1429.
10. Yamagami S, Soejima K. Efect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia. Drugs Exp Clin Res 1989;15(4):171-176.
11. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for Axis I DSM-IV disorders. Research version-patient edition (SCID-I/P, Ver. 2.0). New York (NY): New York State Psychiatric Institute, Biometrics Research Department; 1996.
12. Sadock BJ, Sadock VA. Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. 9th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2003. p.288.
13. Sadock BJ, Sadock VA. Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. 9th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2003. p.1103.
14. Shoja Shafi S. Rehabilitation of schizophrenia: adjunctive therapy of negative symptoms. Iranian Rehabilitation Journal 2004;1(2):26-37. (http://main.uswr.ac.ir/IRJ/)
15. Sharma RP, Singh V, Janicak PG, Javaid JI, Pandey GN. Te prolactin response to fenfuramine in schizophrenia is associated with negative symptoms. Schizophr Res 1999;39(1):85-89.
16. Meltzer HY, Nash JF. Efects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 1991;43(4):587-604.
17. Moller HJ. Non-neuroleptic approaches to treating negative symptoms in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004;254(2):108-116.